Skip to main content

Animations

MJFF Publications

5211 - 5220 of 8571 Results
Title
Year
  • Year
  • 2022
  • 2022
  • 2022
  • 2022
  • 2021
  • 2022
  • 2022
  • 2022
  • 2022
  • 2022
  • Summary Details
    RESTRICTED
    Title: Down‐Regulation of Dopamine Transporter in Early Premotor Phases
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28924
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    RESTRICTED
    Title: What's New at the Journal in 2022
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28906
    Best OA location URL:
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Sex Differences for Clinical Correlates of Alzheimer's Pathology in People with Lewy Body Pathology
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.29044
    Citation Count: 26
  • Summary Details
    RESTRICTED
    Title: Impact of the COVID-19 Pandemic on the Behavioral Health of People With Intellectual and Developmental Disabilities
    Journal Name: Psychiatric Services
    Publisher: American Psychiatric Association Publishing
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1176/appi.ps.202100524
    Best OA location URL:
    Citation Count: 14
  • Summary Details
    OPEN
    Title: Alzheimer’s disease and progressive supranuclear palsy share similar transcriptomic changes in distinct brain regions
    Journal Name: Journal of Clinical Investigation
    Publisher: American Society for Clinical Investigation
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1172/jci149904
    Citation Count: 29
  • Summary Details
    OPEN
    Title: Association of a common genetic variant with Parkinson’s disease is mediated by microglia
    Journal Name: Science Translational Medicine
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1126/scitranslmed.abp8869
    Citation Count: 74
  • Summary Details
    OPEN
    Title: Untwisted α-Synuclein Filaments Formed in the Presence of Lipid Vesicles
    Journal Name: Biochemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.biochem.2c00283
    Citation Count: 9
  • Summary Details
    OPEN
    Title: Library-Derived Peptide Aggregation Modulators of Parkinson’s Disease Early-Onset α-Synuclein Variants
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.2c00190
    Citation Count: 4
  • Summary Details
    RESTRICTED
    Title: Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson’s Disease
    Journal Name: Journal of Medicinal Chemistry
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jmedchem.2c01605
    Best OA location URL:
    Citation Count: 16
  • Summary Details
    OPEN
    Title: How Prolonged Isolation Affects People With Parkinson Disease During the COVID-19 Pandemic
    Journal Name: JAMA
    Publisher: American Medical Association (AMA)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1001/jama.2022.1510
    Citation Count: 5
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.